Weight Loss: Over 6 months, patients on exenatide lost on average ~45 kg (811 lbs), whereas those on comparator therapies often lost little or even gained weight ( [6] ) ( [61] )
So, let's talk about expectation and anxiety, because those two factors can powerfully modulate our experience of both pleasure and pain in ways that will allow us to dial up pleasure, if we like, and to dial down pain, if indeed that's what we want to do
Moreover, in the pioglitazone group, there was a significant resolution of NASH, significant improvement in all the single main features of NASH (steatosis, inflammation, and ballooning necrosis), and significant reduction in the fibrosis score
That doesnt change the amount of supply available, but it may make it easier for people to connect to a medicine they want and need, the Lilly CEO said.Lilly also offers a similar telehealth prescription and delivery service for some of its migraine and diabetes drugs.
10.1016/j.neuroscience.2015.05.023 9 AnderbergR
Orforglipron is a non peptide based GLP1 analog It will be significantly cheaper Comparing it with Wegovy it's 1/10 of the monthly cost for cash payer in USA and as low as 25$ per month for I insurance payers But which methods help reach the goal faster
